Coral Hanevold

Dr. Coral Hanevold

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2004 in Pediatrics
Verified
Journal Article
Closed access
PDF file
CHCoral Hanevold
Coral Hanevold
JWJennifer Waller
Jennifer Waller
SDStephen Daniels
Stephen Daniels
RPRonald Portman
Ronald Portman
JSJonathan Sorof
Jonathan Sorof
Objective. To determine the prevalence of left ventricular hypertrophy (LVH) in a multiethnic group of children and adolescents with hypertension. Design/Methods. Pooled data from 1998 to 2001 from 3 sites belonging to the International Pediatric Hypertension Association were reviewed. Patients undergoing echocardiography to detect LVH as part of the evaluation for hypertension were included for analysis. Left ventricular mass was calculated from 2-dimensional guided M-mode echocardiographic measurements of the left ventricle. Left ventricular mass index (LVMI) was calculated as left ventricular mass/height2.7. LVH by adult criteria was defined as LVMI > 51 g/m2.7 and by pediatric criteria as LVMI > 38.6 g/m2.7. Left ventricle geometry was classified as concentric, concentric remodeling, eccentric, or normal. Results. Data on 129 patients with a mean age of 13.6 ± 3.6 years were analyzed. The population was 67% male, 46.5% white, 38.0% African American, and 15.5% Hispanic. The prevalence of LVH was 15.5% using adult criteria and 41.1% using pediatric criteria. Increasing body mass index (BMI) was associated with a higher LVMI. Using either pediatric or adult criteria LVH was associated with BMI ≥95th percentile for age and gender. LVH and concentric hypertrophy were identified most frequently in Hispanic children. Conclusions. LVH occurs commonly in children with hypertension and is associated with an increased BMI. LVH may be more prevalent in Hispanic children than in other ethnic groups. Prevention and treatment of obesity is important in reducing the cardiovascular risk for children with hypertension. Further evaluation of the frequency of LVH in multiethnic populations is needed.

19 December 2006 in Circulation
Verified
Journal Article
Closed access
XWXiaoling Wang
Xiaoling Wang
JPJoseph C. Poole
Joseph C. Poole
FTFrank A. Treiber
Frank A. Treiber
GHGregory A. Harshfield
Gregory A. Harshfield
CHCoral Hanevold
Coral Hanevold
HSHarold Snieder
Harold Snieder
Background— Cross-sectional studies demonstrated ethnic and gender differences in ambulatory blood pressure patterns, but little is known about the longitudinal development of these differences. Methods and Results— Twenty-four-hour ambulatory blood pressure was measured up to 12 times (5 times on average) over a 15-year period in 312 African Americans (AAs) and 351 European Americans aged 7 to 30 years. Multivariate individual growth curves across age were created for daytime and nighttime blood pressure jointly. For both daytime and nighttime systolic blood pressure (SBP), AAs and males had higher levels ( P <0.001) than European Americans and females. Males also showed a greater increase with age ( P <0.001) than females. For nighttime SBP, a faster increase of SBP with age ( P <0.01) in AAs was additionally observed. The ethnic difference in nighttime SBP levels and its increase with age were significantly larger than in daytime SBP. For daytime and nighttime diastolic blood pressure, AAs had higher levels than European Americans ( P <0.001), and this difference was significantly larger at night. From late adolescence onward, males showed a greater increase in diastolic blood pressure with age than females. Ethnic and gender differences persisted after adjustment for height, body mass index, socioeconomic status, and stress-related coping styles. Family history of essential hypertension explained ethnic differences in daytime SBP. Conclusions— We observed significant ethnic and gender differences in longitudinal trajectories of ambulatory blood pressure in youth and young adults. The blunted nocturnal decline and its exacerbation with age in AAs corroborate and extend findings of cross-sectional studies.

1 February 2005 in Pediatrics
Verified
Journal Article
Closed access
PDF file
CHCoral Hanevold
Coral Hanevold
PHPing-Leung Ho
Ping-Leung Ho
LTLynya Talley
Lynya Talley
MMMark M. Mitsnefes
Mark M. Mitsnefes
Objective. Obesity is increasing in the end-stage renal disease population. Studies that have evaluated the effect of obesity on transplant outcomes in adults have yielded varying results. This issue has received little attention in the pediatric population.

1 September 2019 in Hypertension
Verified
Journal Article
Closed access
EUElaine M. Urbina
Elaine M. Urbina
BMBrenda Mendizábal
Brenda Mendizábal
RBRichard C. Becker
Richard C. Becker
SDSteve R. Daniels
Steve R. Daniels
BFBonita E. Falkner
Bonita E. Falkner
JFJoseph T. Flynn
Joseph T. Flynn
Hypertension is associated with left ventricular hypertrophy (LVH), a risk factor for cardiovascular events. Since cardiovascular events in youth are rare, hypertension has historically been defined by the 95th percentile of the normal blood pressure (BP) distribution in healthy children. The optimal BP percentile associated with LVH in youth is unknown. We aimed to determine the association of systolic BP (SBP) percentile, independent of obesity, on left ventricular mass index (LVMI), and to estimate which SBP percentile best predicts LVH in youth. We evaluated SBP, anthropometrics, and echocardiogram in 303 adolescents (mean age 15.6 years, 63% white, 55% male) classified by SBP as low-risk (L=141, <80th percentile), mid-risk (M=71, 80–<90th percentile), or high-risk (H=91, ≥90th percentile) using the mean of 6 measurements at 2 visits according to the 2017 guidelines. Logistic regression was used to determine the sensitivity and specificity of various SBP percentiles associated with LVH. Results: BP groups did not differ by age or demographics but differed slightly by body mass index. Mean BP, LVMI, and prevalence of LVH increased across groups (BP: L=111/75, M=125/82, and H=133/92 mm Hg; LVMI: L=31.2, M=34.2, and H=34.9 g/m 2.7 ; LVH: L=13%, M=21%, H=27%, all P <0.03). SBP percentile remained a significant determinant of LVMI after adjusting for covariates. The 90th percentile for SBP resulted in the best balance between sensitivity and specificity for predicting LVH (LVMI≥38.6 g/m 2.7 ). Abnormalities in cardiac structure in youth can be found at BP levels below those used to define hypertension.

1 March 2007 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
KMKathleen T. McKie
Kathleen T. McKie
CHCoral Hanevold
Coral Hanevold
CHCaterina Hernandez
Caterina Hernandez
JWJennifer L. Waller
Jennifer L. Waller
LOLuis Ortiz
Luis Ortiz
KMKathleen M. McKie
Kathleen M. McKie
Microalbuminuria (MA) and proteinuria (P) are believed to be precursors of sickle cell nephropathy. We analyzed our longitudinal data on MA/P in children with sickle cell disease (SS) to define the age of onset, association with age, sex, and hemoglobin, and to explore the safety and efficacy of hydroxyurea and angiotensin converting enzyme inhibitor (ACEI) therapy. Data on 191 patients with SS (ages 3 to 20 y) with a mean follow up of 2.19 years±2.05 were available. Urine MA was measured yearly with follow-up testing if abnormal. Prevalence of MA/P was 19.4%. Increasing age and lower hemoglobin levels were related to MA/P but sex was not. Microalbumin excretion normalized in 44% of patients treated with hydroxyurea and 56% of patients treated with ACEI. Hyperkalemia developed in 4 ACEI patients resulting in discontinuation of treatment in 3 children. In summary, MA/P often develops in childhood and preventive and treatment strategies for sickle cell nephropathy should be a focus of pediatric programs. Our preliminary data suggest that although both hydroxyurea and ACEI therapy may be beneficial for MA/P, hyperkalemia may limit the utility of ACEI.

26 August 2015 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
IMIan R. Macumber
Ian R. Macumber
NWNoel S. Weiss
Noel S. Weiss
SHSusan M. Halbach
Susan M. Halbach
CHCoral Hanevold
Coral Hanevold
JFJoseph T. Flynn
Joseph T. Flynn
Obesity has been linked with abnormal nocturnal dipping of blood pressure (BP) in adults, which in turn is associated with poor cardiovascular outcomes. There are few data regarding abnormal dipping status in the obese pediatric population. The goal of this study was to further describe the relationship between obesity and non-dipping status on ambulatory blood pressure monitor (ABPM) in children. We conducted a cross-sectional study using a database of patients aged 5–21 years who had undergone 24-hour ABPM at Seattle Children’s Hospital from January 2008 through May 2014. Subjects were grouped by body mass index (BMI) into lean (BMI 15th–85th percentile) and obese (BMI >95th percentile) groups. Compared to lean subjects ( n = 161), obese subjects ( n = 247) had a prevalence ratio (PR) for non-dipping of 2.15, adjusted for race (95% confidence interval (CI) = 1.25–3.42). Increasing severity of obesity was not further associated with nocturnal non-dipping. Nocturnal non-dipping was not associated with left ventricular hypertrophy (PR = 1.01, 95% CI = 0.71–1.44). These results suggest that in children, just as in adults, obesity is related to a relatively decreased dipping in nocturnal BP.